2m 2m 2m 2m 2m 2m 2m
CANDEL THERAPEUT (CADL)
NASDAQ
$8.35-$0.02 (-0.30%)
Price as of Oct 22, 2026 7:51 PM EDT- $640.5MMarket Cap
- 59.13%1-Year Change
- BiotechnologyIndustry
CANDEL THERAPEUT (CADL)
$8.35-$0.02 (-0.30%)
CADL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.37 | ||
Change | -$0.27 (-3.13%) | ||
Open | $8.65 | ||
High | $8.82 | ||
Low | $8.35 | ||
Previous Close | $8.64 | ||
Volume | 1,102,647 | ||
30-Day Average Volume | 1,000,733 | ||
1-Week Change | -7.72% | ||
1-Month Change | -25.33% | ||
1-Year Change | 59.13% | ||
3-Year Change | 830.00% | ||
5-Year Change | -14.59% | ||
Fundamentals | |||
Shares Outstanding | 76.5M | ||
Total Assets | $208.1M | ||
Market Cap | $640.5M | ||
Enterprise Value | $486.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$38.9M | ||
Free Cash Flow | -$17.3M | ||
EBIT | -$37.3M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $191.5M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -16 | ||
PEG | 0 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue